← Open Payments lookup

MICHELLE DARNALL: Open Payments

NPI 1346642790 · ARKANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$463 in 23 payments from 11 companies in 2025. Trend: 2023 $16 · 2024 $553 · 2025 $463

Food & beverage: $463
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$48
Novo Nordisk Inc2$44
Sumitomo Pharma America, Inc.1$26
GlaxoSmithKline, LLC.1$24
Axsome Therapeutics, Inc.1$23
Vanda Pharmaceuticals Inc.1$21
Edwards Lifesciences Corporation1$19
Bayer Healthcare Pharmaceuticals Inc.1$18

Products named: AIRSUPRA, CAPLYTA, XIFAXAN, Wegovy, BREZTRI, GEMTESA, TRELEGY ELLIPTA, Auvelity.

Industry payments across KS — which companies pay providers there.